Shire PLC’s (SHP) Buy Rating Reaffirmed at Shore Capital
A number of other brokerages have also weighed in on SHP. HSBC lowered Shire PLC to a hold rating and decreased their target price for the stock from GBX 5,400 ($70.49) to GBX 5,250 ($68.53) in a research report on Monday, September 26th. JPMorgan Chase & Co. reissued an overweight rating on shares of Shire PLC in a research report on Friday, September 23rd. Citigroup Inc. reissued a buy rating on shares of Shire PLC in a research report on Tuesday, September 27th. Berenberg Bank reissued a buy rating and issued a GBX 5,800 ($75.71) target price on shares of Shire PLC in a research report on Tuesday, September 27th. Finally, Goldman Sachs Group Inc. reissued a conviction-buy rating and issued a GBX 6,300 ($82.23) target price on shares of Shire PLC in a research report on Thursday, September 29th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. Shire PLC has a consensus rating of Buy and an average price target of GBX 5,828 ($76.07).
Shire PLC (LON:SHP) traded up 1.60% during trading on Thursday, hitting GBX 5196.00. 2,389,832 shares of the stock were exchanged. Shire PLC has a 1-year low of GBX 2,707.19 and a 1-year high of GBX 5,377.00. The firm’s market capitalization is GBX 35.48 billion. The company has a 50-day moving average price of GBX 4,981.22 and a 200 day moving average price of GBX 4,556.22.
The business also recently disclosed a dividend, which will be paid on Friday, October 7th. Investors of record on Thursday, September 8th will be given a dividend of GBX 3.51 ($0.05) per share. This represents a yield of 0.07%. The ex-dividend date of this dividend is Thursday, September 8th.
In related news, insider Dominic Blakemore acquired 133 shares of the company’s stock in a transaction that occurred on Friday, September 30th. The shares were bought at an average price of GBX 5,010 ($65.40) per share, with a total value of £6,663.30 ($8,697.69).
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.